PTK2, protein tyrosine kinase 2, 5747

N. diseases: 205; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE The FAK/Src/Paxillin (PXN) axis has been implicated in malignant transformation, tumor growth, progression and metastasis. 29135089 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE In 3LL-D122-metastasis, of mice treated with the best combination, both EGFR and uPAR/α5β1 integrin pathways are turn off (I.e expression of uPAR/α5β1; and phosphorylation of EGFR, Stat3, Src and FAK are reduced); and tumor angiogenesis is decreased. 29844873 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 GeneticVariation phenotype BEFREE ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway. 30237308 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation. 29515782 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Furthermore, disaggregation of multicellular EOC spheroids, a behavior associated with dissemination and metastasis, is enhanced by matrix stiffness through a mechanotransduction pathway involving ROCK, actomyosin contractility, and FAK. 29740072 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Moreover, FAK, PI3K, Akt and NF-κB activation were also shown to be involved in CTGF-mediated osteosarcoma metastasis. 29909077 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Therefore, CX3CL1 and its regulation of the EGFR, Src and FAK pathways may be potential targets for the early prevention of spinal metastasis in prostate cancer. 30066854 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Meanwhile, action mechanism studies showed that the targeting liposomes could down-regulate PI3K, MMP-2, MMP-9 and FAK to inhibit tumor metastasis. 30299160 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE MnSOD then converts superoxide into hydrogen peroxide, which activates ERK1/2 to promote tumor cell migration and activates FAK to promote tumor cell adhesion. 30193891 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE In clinical samples, high FAK and pFAK expressions were associated with KIT mutation status, and high FAK expression was also associated with metastasis in GIST. 30149002 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE CLCA2 inhibited tumor metastasis through suppressing epithelial-Mesenchymal transition (EMT) and in-activating FAK/ERK1/2 signaling pathway in NPC cells. 29463274 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE We demonstrated that SMG inhibited cell proliferation/metastasis via FAK/RhoA-regulated mTORC1 pathway. 29986550 2018
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE These results suggest that blocking FAK-Akt1 interaction may prevent perioperative tumor dissemination and that analogs or mimics of this 7 amino acid FAK-derived peptide could impair metastasis. 29228673 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE Collectively, these data demonstrate functional activation of FAK1 in metastases and provide preclinical rationale for targeting this kinase in the setting of advanced ccRCC. 28418903 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE Mechanistically, we determined that FAK were phosphorylated on Tyr397, and were activated by integrin β3, which is important for the CTHRC1-mediated migratory and invasive ability of EOC cells in vitro and i.p. metastasis. 29021002 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Gene set enrichment analysis (GSEA) showed that metastasis, cell cycle and FAK pathways were related with elevated CKAP2 expression. 28522860 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Overexpression of miR-466 caused a marked downregulation of integrated network of RUNX2 target genes such as osteopontin, osteocalcin, ANGPTs, MMP11 including Fyn, pAkt, FAK and vimentin that are known to be involved in migration, invasion, angiogenesis, EMT and metastasis. 28125091 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway. 28251459 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE As recent reports imply that FAK1 is highly associated with tumor cell development and malignancy, the inhibition of FAK1 activity could be an effective therapeutic approach for inhibiting the growth and metastasis of tumor cells. 29048635 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE Cells adorned with longer glycopolymers showed increased metastatic potential, enhanced cell cycle progression, and greater levels of integrin-FAK mechanosignaling and Akt signaling in a syngeneic mouse model of metastasis. 29266001 2017
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway. 27644693 2016
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE In conclusion, AURKA may induce EMT to promote metastasis via activation of the FAK/PI3K pathway in LSCC. 27373675 2016
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE SMARCE1-mediated PTK2 activation likely plays a key role in promoting metastasis of basal-like and luminal B subtype of breast tumors. 27495308 2016
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 Biomarker phenotype BEFREE RT-PCR assays of OS cells incubated with extracellular vesicles (EVs) from SD-MSCs revealed microRNAs that could potentially target metabolism and metastasis associated genes as predicted by in silico algorithms, including monocarboxylate transporters, bone morphogenic receptor type 2, fibroblast growth factor 7, matrix metalloproteinase-1, and focal adhesion kinase-1. 27812189 2016
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.300 AlteredExpression phenotype BEFREE Therefore, phosphorylated FAK Y861 and increased Yes expression may be predictive markers for PCa metastasis. 25868388 2015